{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "12542352", "DateCompleted": {"Year": "2003", "Month": "06", "Day": "20"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "27"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0163-3864", "JournalIssue": {"Volume": "66", "Issue": "1", "PubDate": {"Year": "2003", "Month": "Jan"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Antineoplastic agents 500. Narcistatin.", "Pagination": {"StartPage": "92", "EndPage": "96", "MedlinePgn": "92-6"}, "Abstract": {"AbstractText": ["An efficient procedure was found for synthetic conversion of the sparingly soluble anticancer isocarbostyril narciclasine (1), a component of various Narcissus species, to a cyclic phosphate designated narcistatin (3b). The reaction between narciclasine, tetrabutylammonium dihydrogen phosphate, and p-toluenesulfonic acid in pyridine afforded pyridinium narcistatin (3a) in reasonable yields. Transformation of narcistatin (3a) to, for example, the water-soluble prodrug sodium narcistatin (3d) was easily achieved by cation exchange chromatography. Narcistatin (3b) and 15 salt derivatives were evaluated against a panel of human cancer cell lines, and the range (0.1-0.01) of GI(50) values in micro g/mL was found to parallel that shown by the parent narciclasine."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Research Institute and Department of Chemistry and Biochemistry, Arizona State University, Tempe, Arizona 85287-2404, USA."}], "Identifier": [], "LastName": "Pettit", "ForeName": "George R", "Initials": "GR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Melody", "ForeName": "Noeleen", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Simpson", "ForeName": "Michael", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Thompson", "ForeName": "Michael", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Herald", "ForeName": "Delbert L", "Initials": "DL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Knight", "ForeName": "John C", "Initials": "JC"}], "GrantList": [{"GrantID": "CA44344-03-12", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "R01 CA90441-01", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S.", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Amaryllidaceae Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Heterocyclic Compounds, 4 or More Rings"}, {"RegistryNumber": "0", "NameOfSubstance": "Organophosphates"}, {"RegistryNumber": "0", "NameOfSubstance": "Organophosphorus Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Phenanthridines"}, {"RegistryNumber": "0", "NameOfSubstance": "Prodrugs"}, {"RegistryNumber": "0", "NameOfSubstance": "Quaternary Ammonium Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "narcistatin"}, {"RegistryNumber": "29477-83-6", "NameOfSubstance": "narciclasine"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Amaryllidaceae Alkaloids"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Division"}, {"QualifierName": [], "DescriptorName": "Crystallography, X-Ray"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Heterocyclic Compounds, 4 or More Rings"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Leukemia P388"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Molecular Conformation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry"], "DescriptorName": "Narcissus"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Organophosphates"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Organophosphorus Compounds"}, {"QualifierName": [], "DescriptorName": "Phenanthridines"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Prodrugs"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Quaternary Ammonium Compounds"}, {"QualifierName": ["drug effects"], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2003", "Month": "1", "Day": "25", "Hour": "4", "Minute": "0"}, {"Year": "2003", "Month": "6", "Day": "21", "Hour": "5", "Minute": "0"}, {"Year": "2003", "Month": "1", "Day": "25", "Hour": "4", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["12542352", "10.1021/np020225i"]}}], "PubmedBookArticle": []}